Breast Magnetic Resonance Imaging: Current Clinical Indications

Magnetic Resonance Imaging Clinics of North America

Volumn 18, Issue 2, 2010, Pages 155-169

  Yeh, Eren D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast; Breast cancer; Indications; Magnetic resonance

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; PACLITAXEL;

BREAST AUGMENTATION; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG RESPONSE; ECHOMAMMOGRAPHY; HIGH RISK PATIENT; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PREDICTION; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION;

BREAST; BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMAPLASTY; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 77953004756     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2010.02.009     Document Type: Review

References (58)

1. American Cancer Society Available at:, Accessed 2009. http://www.cancer.org.
2. Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007, 244(2):356-378.
3. American College of Radiology ACR Breast Imaging Reporting and Data System (BIRADS): breast imaging atlas 2003, American College of Radiology, Reston (VA). 4th edition.
4. American College of Radiology Available at:, Accessed 2009. http://www.acr.org.
5. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57(2):75-89.
6. Kuhl C.K., Schmutzler R.K., Leutner C.C., et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000, 215(1):267-279.
7. Kuhl C.K. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 2007, 244(3):672-691.
8. Lehman C.D. Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 2006, 24(5):964-970.
9. Liberman L. Breast cancer screening with MRI-what are the data for patients at high risk?. N Engl J Med 2004, 351(5):497-500.
10. Lee L., Pintilie M., Hodgson D.C., et al. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma. Ann Oncol 2008, 19(1):62-67.
11. De Bruin M.L., Sparidans J., van't Veer M.B., et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009, 27(26):4239-4246.
12. Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am 2006, 14(3):339-349. vi.
13. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356(13):1295-1303.
14. Heywang S.H., Hilbertz T., Beck R., et al. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants. J Comput Assist Tomogr 1990, 14(3):348-356.
15. Goodman C.M., Cohen V., Thornby J., et al. The life span of silicone gel breast implants and a comparison of mammography, ultrasonography, and magnetic resonance imaging in detecting implant rupture: a meta-analysis. Ann Plast Surg 1998, 41(6):577-585. [discussion: 585-576].
16. Ikeda D.M., Borofsky H.B., Herfkens R.J., et al. Silicone breast implant rupture: pitfalls of magnetic resonance imaging and relative efficacies of magnetic resonance, mammography, and ultrasound. Plast Reconstr Surg 1999, 104(7):2054-2062.
17. Soo M.S., Kornguth P.J., Walsh R., et al. Intracapsular implant rupture: MR findings of incomplete shell collapse. J Magn Reson Imaging 1997, 7(4):724-730.
18. Houssami N., Ciatto S., Macaskill P., et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008, 26(19):3248-3258.
19. Orel S. Who should have breast magnetic resonance imaging evaluation?. J Clin Oncol 2008, 26(5):703-711.
20. Braun M., Polcher M., Schrading S., et al. Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast Cancer Res Treat 2008, 111(1):179-187.
21. Morris E.A., Schwartz L.H., Drotman M.B., et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology 2000, 214(1):67-72.
22. Kazama T., Nakamura S., Doi O., et al. Prospective evaluation of pectoralis muscle invasion of breast cancer by MR imaging. Breast Cancer 2005, 12(4):312-316.
23. Yeh E.D., Slanetz P.J., Edmister W.B., et al. Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J 2003, 9(1):13-18.
24. Kumar V., Abbas A.K., Fausto N., et al. Robbins and Cotran pathologic basis of disease 2005, Elsevier Saunders, Philadelphia. 7th edition.
25. Rodenko G.N., Harms S.E., Pruneda J.M., et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol 1996, 167(6):1415-1419.
26. Mann R.M., Hoogeveen Y.L., Blickman J.G., et al. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 2008, 107(1):1-14.
27. Van Goethem M., Schelfout K., Dijckmans L., et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 2004, 14(5):809-816.
28. Ikeda O., Nishimura R., Miyayama H., et al. Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer. Acta Radiol 2004, 45(7):721-725.
29. Van Goethem M., Schelfout K., Kersschot E., et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol 2007, 62(2):273-282.
30. Schouten van der Velden A.P., Boetes C., Bult P., et al. Magnetic resonance imaging in size assessment of invasive breast carcinoma with an extensive intraductal component. BMC Med Imaging 2009, 9:5.
31. Godinez J., Gombos E.C., Chikarmane S.A., et al. Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation. AJR Am J Roentgenol 2008, 191(1):272-277.
32. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004, 14(10):1725-1731.
33. Solin L.J., Orel S.G., Hwang W.T., et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008, 26(3):386-391.
34. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998, 16(8):2672-2685.
35. Bonadonna G., Valagussa P. Primary chemotherapy in operable breast cancer. Semin Oncol 1996, 23(4):464-474.
36. Yeh E., Slanetz P., Kopans D.B., et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 2005, 184(3):868-877.
37. Segara D., Krop I.E., Garber J.E., et al. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?. J Surg Oncol 2007, 96(6):474-480.
38. Rosen E.L., Blackwell K.L., Baker J.A., et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 2003, 181(5):1275-1282.
39. Partridge S.C., Gibbs J.E., Lu Y., et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002, 179(5):1193-1199.
40. Helvie M.A., Joynt L.K., Cody R.L., et al. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 1996, 198(2):327-332.
41. Qayyum A., Birdwell R.L., Daniel B.L., et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 2002, 178(5):1227-1232.
42. Weinstein S.P., Orel S.G., Heller R., et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 2001, 176(2):399-406.
43. Denis F., Desbiez-Bourcier A.V., Chapiron C., et al. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 2004, 30(10):1069-1076.
44. Taghian A.G., Abi-Raad R., Assaad S.I., et al. Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications. J Clin Oncol 2005, 23(9):1951-1961.
45. Gilles R., Guinebretiere J.M., Shapeero L.G., et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 1993, 188(2):473-478.
46. Dao T.H., Rahmouni A., Campana F., et al. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993, 187(3):751-755.
47. Harris J.R. Diseases of the breast 2004, Lippincott Williams & Wilkins, Philadelphia. 3rd edition.
48. Jackson B., Scott-Conner C., Moulder J. Axillary metastasis from occult breast carcinoma: diagnosis and management. Am Surg 1995, 61(5):431-434.
49. Fortunato L., Sorrento J.J., Golub R.A., et al. Occult breast cancer. A case report and review of the literature. N Y State J Med 1992, 92(12):555-557.
50. Olson J.A., Morris E.A., Van Zee K.J., et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000, 7(6):411-415.
51. Morris E.A., Schwartz L.H., Dershaw D.D., et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997, 205(2):437-440.
52. Orel S.G., Weinstein S.P., Schnall M.D., et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999, 212(2):543-549.
53. Ko E.Y., Han B.K., Shin J.H., et al. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol 2007, 8(5):382-389.
54. Varadarajan R., Edge S.B., Yu J., et al. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology 2006, 71(5-6):456-459.
55. Sardanelli F., Melani E., Ottonello C., et al. Magnetic resonance imaging of the breast in characterizing positive or uncertain mammographic findings. Cancer Detect Prev 1998, 22(1):39-42.
56. Lee C.H., Smith R.C., Levine J.A., et al. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram. AJR Am J Roentgenol 1999, 173(5):1323-1329.
57. Moy L., Elias K., Patel V., et al. Is breast MRI helpful in the evaluation of inconclusive mammographic findings?. AJR Am J Roentgenol 2009, 193(4):986-993.
58. Lehman C.D., DeMartini W., Anderson B.O., et al. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw 2009, 7(2):193-201.